EFFICACY Archives - NATA ONLINE

Published on Apr 2004

Preoperative acute normovolemic hemodilution: a meta-analysis.

Segal JB, Blasco-Colmenares E, Norris EJ, Guallar E

Transfusion 2004;44(5):632-644.

Review by

Published on Apr 2003

The use of recombinant factor VIIa in children with inherited platelet function disorders.

Almeida AM, Khair K, Hann I, Liesner R

Br J Haematol 2003;121(3):477-481.

Review by Aldouri M

Published on Sep 2002

Effectiveness of acute normovolemic hemodilution to minimize allogeneic blood transfusion in major liver resections.

Matot I, Scheinin O, Jurim O, Eid A

Anesthesiology 2002;97(4):794-800.

Review by Van der Linden P, Messmer K

Published on Mar 2002

Experience with use of recombinant activated factor VII.

Divanon F, Hecquard C, Borel-Derlon A

J Clin Pharm Ther 2002;27(2):133-138.

Review by

Published on Feb 2002

Comparison of the effects of a 50% exchange-transfusion with albumin, hetastarch, and modified hemoglobin solutions.

Lieberthal W, Fuhro R, Alam H, et al.

Shock 2002;17(1):61-69.

Review by

Published on Dec 2001

Oxygen transport dynamics of acellular hemoglobin solutions in an isovolemic hemodilution model in swine.

Vaslef SN, Kaminski BJ, Talarico TL

J Trauma 2001;51(6):1153-1160.

Review by Van der Linden P.

Published on Nov 2000

New products for managing inhibitors to coagulation factors: a focus on recombinant factor VIIa concentrate.

Kessler CM

Curr Opin Hematol 2000;7(6):408-413.

Review by M. Aldouri

NATA: Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis

MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.

Sitemap

Contact us

Follow us

SUBSCRIBE TO OUR NEWSLETTER

Consent Management Platform by Real Cookie Banner